What's new? Log in Free sign up

Filing search / Fusion Pharmaceuticals Inc / "Long-term"

Search information

Fusion Pharmaceuticals Inc

Companies

"Long-term"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

48 results

Newest first Best match first

FUSN Fusion Pharmaceuticals Inc

Quarterly report

Prepaid expenses and other current assets Restricted cash Total current assets Property and equipment, net Deferred tax assets Restricted cash Long-term investments … : Accounts payable Accrued expenses and other current liabilities Deferred revenue Operating lease liabilities Total current liabilities Long-term debt, net

7 May 24

8:00am

FUSN Fusion Pharmaceuticals Inc

Proxy related to merger

of the Arrangement The Board frequently reviews, with Fusion’s senior management and the assistance of outside advisors, Fusion’s long-term plans … and strategic opportunities to increase long-term shareholder value, including accessing the U.S. public markets and seeking partnership and collaboration

FUSN Fusion Pharmaceuticals Inc

Annual report (amended)

. CORPORATE GOVERNANCE General We believe that good corporate governance is important to ensure that our company is managed for the long-term benefit … and advising the board and management regarding the long-term strategic goals and objectives and the quality and direction of our research and development

12 Apr 24

8:00am

FUSN Fusion Pharmaceuticals Inc

Preliminary proxy related to merger

long-term plans and strategic opportunities to increase long-term shareholder value, including accessing the U.S. public markets and seeking partnership … , each of the Transaction Committee and the Board believed that this certainty of value was compelling compared to the uncertain long-term value creation

FUSN Fusion Pharmaceuticals Inc

human clinical trials may begin. Some long-term preclinical testing may continue after the IND is submitted. An IND automatically becomes effective 30 … , assessments of the long-term safety of targeted alpha emitting isotope therapies in humans have been limited, and there may be long-term effects from

20 Mar 24

4:14pm

6tszgsu0 da5bsd4

Additional proxy soliciting materials

Voting and Support Agreement

Prospectus supplement for primary offering

k0mhkzk510jiono

Quarterly report

7 Nov 23

8:00am

yi9rgo 8gde5qtwh3je

Quarterly report

8 Aug 23

8:21am

Shelf registration

16 Jun 23

4:02pm

q0q0c5586xczn1g19jq

Quarterly report

11 May 23

8:01am

Fusion Pharmaceuticals Announces First Quarter 2023 Financial Results and Clinical Program Updates

Definitive proxy

27 Apr 23

4:31pm

Quarterly report

8 Nov 22

8:01am

3v0clwwxoe84n4yz1py

Quarterly report

9 Aug 22

8:01am

6sygctgw p2boajx85y

Quarterly report

9 Aug 22

8:01am

eyzxfjq8furi3opm5

Quarterly report

10 May 22

8:01am

Definitive proxy

29 Apr 22

4:17pm

17 Mar 22

8:01am

Prev
1
2
3
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.